Results per Page:
Colorado patient chooses proton therapy following prostate cancer surgery
With no local proton therapy facilities, patient turned to Fred Hutch for its research and reputation
New clinical trials to target HER2 positive solid cancers
From Dr. Sara Hurvitz, Clinical Research Division, and colleagues
Washington Research Foundation awards $5.2M to establish new clinical trials program
Funds will help develop ‘first-in-human’ trials for new therapeutics invented at Fred Hutch and Seattle Children’s
Data-driven enrollment for COVID-19 vaccine clinical trials
From the HIV Vaccine Trials Network/COVID-19 Prevention Network
Dr. Shailender Bhatia receives the Lyn and Daniel Lerner Endowed Chair in Merkel Cell Carcinoma
A family’s generosity will fuel the search for new ways to treat an aggressive skin cancer
Providing patient care — and hope — for 35 years
Whether it’s helping establish new care models, administering treatment or supervising teams, Fred Hutch registered nurse Phuong Tran infuses support and dedication into patient and staff experiences
Can Entertainment Help Save Lives? A New Study Says Yes—Especially on Social Media
From the Henderson research group, Public Health Sciences Division
One shot to save lives: Can a single HPV vaccine dose do the trick in children living with HIV?
From the Duerr lab, Vaccine and Infectious Disease Division
Magic mushrooms, real results: Psilocybin’s role in healthcare worker healing
From the Gooley Group, Clinical Research Division
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Navigating a brand-new cancer diagnosis
Fred Hutch nurse navigation program expands, reducing waiting time for new appointments and treatment
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
A promising antibody-drug conjugate for treating brain metastases in breast cancer patients
From the Hurvitz Lab, Clinical Research Division